What’s New In Follicular Lymphoma: Updates from ASCO 2024 & the EHA Hybrid Congress

Follicular lymphoma (FL) is a heterogeneous disease with a clinical course that varies from indolent to aggressive, characterized by frequent relapses and shortened overall survival. Fortunately, recent developments have provided great advances in the treatment of both treatment-naïve and relapsed/refractory FL. In this program, Dr. Sairah Ahmed reviews the latest and most pivotal clinical data on the management of FL, as well how best to apply these recent findings in clinical practice. View this program in its entirety https://exchangecme.com/groups/2024NH... Clinical Resources in NHL https://exchangecme.com/NHLConference... ExchangeCME.com is an online community of more than 57,000 active healthcare professionals who have access to a variety of enduring educational activities and other disease state–focused resources. The Website’s core mission is to support patient-centered care via education that is tailored to the needs of various clinician audiences. By consolidating evidence-based resources and hosting only accredited educational programs without any promotional content or advertising, ExchangeCME.com serves as an independent, trusted, and balanced source of free CME/CE for physicians, nurses, pharmacists, and other healthcare providers. meded #CME #hematology #oncology #nonhodgkinlymphoma #NHL #lymphoma Follow us on social! twitter:   / exchangecme   facebook:   / exchangecme   linkedin:   / exch.  .